Gossamer Bio, Inc.

Gossamer Bio, Inc.verified

GOSS

Price:

$3.32

Market Cap:

$753.86M

Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colonystimulating factor 1 receptor, or CSF1R, and c-KIT inhibitor for the treatment of pulmonary arterial hypertension; GB004, a gut-targeted, oral small molecule for the treatment of inflammatory bowel disease; GB5121, an oral, irreversible, covalent, small molecule inhibitor of Bruton's Tyrosine Kinase for the treatment of primary central nervous system ...[Read more]

Industry

Biotechnology

IPO Date

2019-02-08

Stock Exchange

NASDAQ

Ticker

GOSS

The Enterprise Value as of December 2025 (TTM) for Gossamer Bio, Inc. (GOSS) is 930.39M

According to Gossamer Bio, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 930.39M. This represents a change of 126.98% compared to the average of 409.89M of the last 4 quarters.

Gossamer Bio, Inc. (GOSS) Historical Enterprise Value (quarterly & annually)

How has GOSS Enterprise Value performed in the past?

The mean historical Enterprise Value of Gossamer Bio, Inc. over the last ten years is 511.93M. The current 930.39M Enterprise Value has changed 18.07% with respect to the historical average. Over the past ten years (40 quarters), GOSS's Enterprise Value was at its highest in in the June 2019 quarter at 1.25B. The Enterprise Value was at its lowest in in the March 2017 quarter at 0.

Quarterly (TTM)
Annual

Average

511.93M

Median

386.19M

Minimum

164.33M

Maximum

978.39M

Gossamer Bio, Inc. (GOSS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Gossamer Bio, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 174.57%

Maximum Annual Enterprise Value = 978.39M

Minimum Annual Increase = -64.95%

Minimum Annual Enterprise Value = 164.33M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2024361.45M-6.41%
2023386.19M29.90%
2022297.29M-64.95%
2021848.31M135.53%
2020360.17M-52.61%
2019760.05M-22.32%
2018978.39M116.84%
2017451.20M174.57%

Gossamer Bio, Inc. (GOSS) Average Enterprise Value

How has GOSS Enterprise Value performed in the past?

The current Enterprise Value of Gossamer Bio, Inc. (GOSS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

348.31M

5-year avg

450.68M

10-year avg

511.93M

Gossamer Bio, Inc. (GOSS) Enterprise Value vs. Peers

How is GOSS’s Enterprise Value compared to its peers?

Gossamer Bio, Inc.’s Enterprise Value is greater than KalVista Pharmaceuticals, Inc. (710.80M), greater than 4D Molecular Therapeutics, Inc. (496.31M), less than Olema Pharmaceuticals, Inc. (1.86B), greater than Ventyx Biosciences, Inc. (548.92M), greater than Lexicon Pharmaceuticals, Inc. (556.11M), greater than Rigel Pharmaceuticals, Inc. (857.90M), greater than Prothena Corporation plc (278.98M), greater than Corvus Pharmaceuticals, Inc. (655.78M), greater than RAPT Therapeutics, Inc. (534.71M), greater than REGENXBIO Inc. (674.74M),

Build a custom stock screener for Gossamer Bio, Inc. (GOSS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Gossamer Bio, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Gossamer Bio, Inc. (GOSS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Gossamer Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Gossamer Bio, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Gossamer Bio, Inc. (GOSS)?

What is the 3-year average Enterprise Value for Gossamer Bio, Inc. (GOSS)?

What is the 5-year average Enterprise Value for Gossamer Bio, Inc. (GOSS)?

How does the current Enterprise Value for Gossamer Bio, Inc. (GOSS) compare to its historical average?